• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Sandra Siegel, Andreas Wagner, +6 authors Matthias Zeis
  • Biology, Medicine
  • Blood
  • 2003 (First Publication: 15 December 2003)
  • The oncofetal antigen immature laminin receptor protein (OFA-iLRP) is a highly conserved protein that is preferentially expressed in fetal tissues and in many types of cancer, including hematopoieticContinue Reading
  • Chris Lehmann, Matthias Zeis, Lutz L. Uharek
  • Medicine, Biology
  • British journal of haematology
  • 2001 (First Publication: 1 September 2001)
  • Natural killer (NK) cells can lyse a variety of different tumour cells by exocytosis of perforin, subsequent binding of perforin to the target cell membrane and formation of lytic pores. Some tumourContinue Reading
  • Birte Friedrichs, Sandra Siegel, +11 authors Matthias Zeis
  • Medicine
  • Journal of immunology
  • 2008 (First Publication: 1 May 2008)
  • Chronic lymphocytic leukemia (CLL) is characterized by a highly variable clinical course. The role of an autologous tumor-specific immune control contributing to the variable length of survival inContinue Reading
  • Matthias Zeis, Sandra Siegel, +8 authors Axel Heiser
  • Biology, Medicine
  • Journal of immunology
  • 2003 (First Publication: 1 June 2003)
  • Survivin is a member of the inhibitors of apoptosis family and is overexpressed in many types of human cancers, making it an attractive target for T cell-based immunotherapeutic strategies. Recently,Continue Reading
  • Matthias Zeis, Lutz L. Uharek, +4 authors Norbert Schmitz
  • Medicine
  • British journal of haematology
  • 1997 (First Publication: 1 March 1997)
  • Allogeneic lymphocytes administered with an unmanipulated bone marrow transplant provide a strong antileukaemic effect, the so-called graft-versus-leukaemia (GVL) effect. On the other hand,Continue Reading
  • Matthias Zeis, Lutz L. Uharek, Gernot Hartung, Bertram A. Glass, Joerg Steinmann, Norbert Schmitz
  • Medicine
  • The hematology journal : the official journal of…
  • 2001
  • INTRODUCTION The transfer of allogeneic lymphocytes contained in a hematopoietic stem cell graft confers an immune-mediated antileukemic effect, termed the graft-vs-leukemia (GVL) effect.Continue Reading